Clinical Trial

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Name: An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma — clinical trial record (NCT07493044)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-19.

Trial Details

NCT Number	NCT07493044
Lead Sponsor	Guangzhou FineImmune Biotechnology Co., LTD. Collaborators: Sun Yat-Sen University Cancer Center
Conditions	Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma
Enrollment	15 participants
Start Date	2026-03-27
Primary Completion	2028-04-30 (estimated)
Study Completion	2028-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-14